Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance
Open Access
- 30 September 2019
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 3 (19) , 2804-2811
Abstract
Key Points: Practices in early-stage FL are variable and include radiation alone, systemic therapy, CMT, or observation. Each practice resulted in similar excellent outcomes; randomized trials are required to determine the optimal treatment.Keywords
This publication has 29 references indexed in Scilit:
- Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?Journal of Hematology & Oncology, 2013
- Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare StudyJournal of Clinical Oncology, 2012
- Improved survival in patients with early stage low‐grade follicular lymphoma treated with radiationCancer, 2010
- Long‐term outcomes for patients with limited stage follicular lymphomaCancer, 2010
- Long-term outcome and mortality trends in early-stage, Grade 1–2 follicular lymphoma treated with radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune CellsNew England Journal of Medicine, 2004
- Follicular Lymphoma International Prognostic IndexBlood, 2004
- Stage I and II Follicular Non-Hodgkin’s Lymphoma: Long-Term Follow-Up of No Initial TherapyJournal of Clinical Oncology, 2004
- Long-Term Follow-Up of a Prospective Study of Combined Modality Therapy for Stage I–II Indolent Non-Hodgkin’s LymphomaJournal of Clinical Oncology, 2003
- Localized grade I non-Hodgkin's lymphoma: Results of treatment with radiotherapy alone in 88 patientsClinical Oncology, 1989